Cargando…
Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey
The observed epidemiology of SARS-CoV-2 in sub-Saharan Africa has varied greatly from that in Europe and the United States, with much lower reported incidence. Population-based studies are needed to estimate true cumulative incidence of SARS-CoV-2 to inform public health interventions. This study es...
Autores principales: | Audu, Rosemary A., Stafford, Kristen A., Steinhardt, Laura, Musa, Zaidat A., Iriemenam, Nnaemeka, Ilori, Elsie, Blanco, Natalia, Mitchell, Andrew, Hamada, Yohhei, Moloney, Mirna, Iwara, Emem, Abimiku, Alash’le, Ige, Fehintola A., William, Nwachukwu E., Igumbor, Ehimario, Ochu, Chinwe, Omoare, Adesuyi A., Okunoye, Olumide, Greby, Stacie M., Rangaka, Molebogeng X., Copas, Andrew, Dalhatu, Ibrahim, Abubakar, Ibrahim, McCracken, Stephen, Alagi, Matthias, Mba, Nwando, Anthony, Ahumibe, Okoye, McPaul, Okoi, Catherine, Ezechi, Oliver C., Salako, Babatunde L., Ihekweazu, Chikwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022353/ https://www.ncbi.nlm.nih.gov/pubmed/36962359 http://dx.doi.org/10.1371/journal.pgph.0000363 |
Ejemplares similares
-
Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
por: Ige, Fehintola, et al.
Publicado: (2021) -
Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018)
por: Jahun, Ibrahim, et al.
Publicado: (2022) -
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
por: Rangaka, Molebogeng X, et al.
Publicado: (2022) -
Evaluation of the Nigeria national HIV rapid testing algorithm
por: Iriemenam, Nnaemeka C., et al.
Publicado: (2022) -
Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria
por: Iriemenam, Nnaemeka C., et al.
Publicado: (2022)